anti-angiogenic miRNA-based therapeutics (InteRNA Technologies)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameanti-angiogenic miRNA-based therapeutics (InteRNA Technologies)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Renal CellGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInterna Technologies Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInterna Technologies Bv
Active IndicationsN/A
Inactive IndicationsCarcinoma, Renal CellGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A